ClinicalTrials.gov record
Completed Phase 3 Interventional

Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer

ClinicalTrials.gov ID: NCT00003170

Public ClinicalTrials.gov record NCT00003170. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 7, 2026, 9:36 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase III Double-Blind Study of Glutamine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy

Study identification

NCT ID
NCT00003170
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Alliance for Clinical Trials in Oncology
Other
Enrollment
129 participants

Conditions and interventions

Conditions

Interventions

  • glutamine Dietary Supplement
  • placebo Other

Dietary Supplement · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 1998
Primary completion
Apr 30, 2003
Completion
May 31, 2003
Last update posted
Jul 13, 2016

1998 – 2003

United States locations

U.S. sites
17
U.S. states
11
U.S. cities
17
Facility City State ZIP Site status
CCOP - Scottsdale Oncology Program Scottsdale Arizona 85259-5404
CCOP - Illinois Oncology Research Association Peoria Illinois 61602
CCOP - Carle Cancer Center Urbana Illinois 61801
CCOP - Cedar Rapids Oncology Project Cedar Rapids Iowa 52403-1206
CCOP - Iowa Oncology Research Association Des Moines Iowa 10309-1016
Siouxland Hematology-Oncology Sioux City Iowa 51101-1733
CCOP - Wichita Wichita Kansas 67214-3882
CCOP - Ann Arbor Regional Ann Arbor Michigan 48106
CCOP - Duluth Duluth Minnesota 55805
Mayo Clinic Cancer Center Rochester Minnesota 55905
CentraCare Clinic Saint Cloud Minnesota 56303
CCOP - Missouri Valley Cancer Consortium Omaha Nebraska 68131
Quain & Ramstad Clinic, P.C. Bismarck North Dakota 58501
CCOP - Merit Care Hospital Fargo North Dakota 58122
CCOP - Toledo Community Hospital Oncology Program Toledo Ohio 43623-3456
CCOP - Geisinger Clinical and Medical Center Danville Pennsylvania 17822-2001
CCOP - Sioux Community Cancer Consortium Sioux Falls South Dakota 57105-1080

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00003170, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 13, 2016 · Synced May 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00003170 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →